* Dolby Laboratories Inc DLB.N DLB is expected to show a
fall
in quarterly revenue when it reports results on February 2.
* The San Francisco California-based company is expected to
report a 12.8% decrease in revenue to $306.558 million from
$351.63 million a year ago, according to the mean estimate from
4 analysts, based on Refinitiv data. The company's guidance on
November 17 2022, for the period ended December 31, was for
revenue between $300.00 million and $330.00 million.
* Refinitiv's mean analyst estimate for Dolby Laboratories
Inc is
for earnings of 79 cents per share. The company's EPS guidance
on November 17 2022, for the period ended December 31, was
between $0.76 and $0.91
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 14.9%
in the last three months.
* Wall Street's median 12-month price target for Dolby
Laboratories Inc is $82.5, above its last closing price
of $79.56.
The company's guidance on November 17 2022 for the period ended
December 31 was for gross profit margin of USD90%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.51 0.60 0.54 Missed -10
Jun. 30 2022 0.59 0.59 0.68 Beat 16.2
Mar. 31 2022 0.82 0.82 0.92 Beat 12.7
Dec. 31 2021 1.06 1.06 1.01 Missed -4.9
Sep. 0.56 0.56 0.58 Beat 3.1
30 2021
Jun. 30 2021 0.48 0.48 0.71 Beat 49.5
Mar. 31 2021 0.67 0.67 0.91 Beat 36.5
Dec. 31 2020 1.04 1.04 1.48 Beat 41.8
This summary was machine generated February 1 at 00:21 GMT. All
figures in US dollars unless otherwise stated